JACOBS LEVY EQUITY MANAGEMENT, INC

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 884414 FLORHAM PARK, NJ

Position in AUPH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$20,898,826

+$4,638,486 QoQ

Shares Held

1,231,516

+12.2% QoQ

Ownership

0.926%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#14

of 279 holders

Holding Since

Sep 2022

8 quarters on record

Voting authority Sole 86% Shared 0% None 14%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. AUPH ranks #7 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	256,503	$159,939,880
2	RARE	Ultragenyx Pharmaceutical Inc.	2,939,719	$98,157,217
3	INCY	Incyte Corp	731,774	$82,953,900
4	CORT	Corcept Therapeutics Inc	695,532	$60,476,507
5	HALO	Halozyme Therapeutics, Inc.	322,377	$25,232,447
6	EXEL	Exelixis, Inc.	415,650	$22,615,516
7	AUPH	Aurinia Pharmaceuticals Inc. This page	1,231,516	$20,898,826
8	ALNY	Alnylam Pharmaceuticals, Inc.	60,986	$18,358,615

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,898,826	1,231,516	+12.2%	Shares	Sole	2026-08-14
2026-03-31	$16,260,340	1,097,189	-3.7%	Shares	Sole	2026-05-15
2025-12-31	$18,171,021	1,139,249	-6.6%	Shares	Sole	2026-02-13
2025-09-30	$13,474,933	1,219,451	+63.0%	Shares	Sole	2025-11-17
2025-06-30	$6,336,517	748,113	+135.5%	Shares	Sole	2025-08-14
2025-03-31	$2,553,954	317,656	+2299.9%	Shares	Sole	2025-05-15
2024-12-31	$118,859	13,236	-62.7%	Shares	Sole	2025-02-14
2022-09-30	$266,839	35,484	—	Shares	Sole	2022-11-15
No filing history on record for this holder in this stock.